HCID 14664366, compound → HCID 14664368, compound
Reaction equation
[N:1]1([C:6]2[CH:26]=[CH:25][C:9]([C:10]([N:12]3[CH2:17][CH2:16][N:15](CC4C=CC=CC=4)[CH2:14][CH2:13]3)=[O:11])=[CH:8][CH:7]=2)[CH:5]=[CH:4][N:3]=[CH:2]1>C(O)C.[Pd].O>[N:1]1([C:6]2[CH:7]=[CH:8][C:9]([C:10]([N:12]3[CH2:17][CH2:16][NH:15][CH2:14][CH2:13]3)=[O:11])=[CH:25][CH:26]=2)[CH:5]=[CH:4][N:3]=[CH:2]1Participants
5
Reactant 1
Product 1
Reagents, catalysts & solvents 3
Conditions
- Temperature
- 50 °C
Procedure
1-[4-(1H-Imidazol-1-yl)benzoyl]-4-(phenylmethyl)piperazine (26.65 g, 76.9 mmol) is dissolved in ethanol (500 mL) and 10% palladium on carbon (2.00 g) as a slurry in water (10 mL) is added to the solution. The mixture is shaken under an atmosphere of hydrogen on a Parr apparatus at 50 psi and 50° C. for 30 hr. The mixture is filtered through Celite, the solvent is evaporated, and the residue is triturated with ether and crystallized from ethyl acetate-hexane to afford the title compound.
Workup
- filtrationThe mixture is filtered through Celite
- customthe solvent is evaporated
- customthe residue is triturated with ether
- customcrystallized from ethyl acetate-hexane
Sources & evidence
- ORD record
- ord-bc117e2d6b874e07b60ed269d7ec8cfa
- Source dataset
- uspto-grants-1993_02
- Patent number
- US05189036
Reaction notes
Loading…